Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York
Anthony P. West, Joel O. Wertheim, Jade Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

SARS-CoV-2 variants, spike mutations and immune escape
William T. Harvey, Alessandro M. Carabelli, Ben Jackson, et al.
Nature Reviews Microbiology (2021) Vol. 19, Iss. 7, pp. 409-424
Open Access | Times Cited: 3370
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
Zijun Wang, Frauke Muecksch, Dennis Schaefer-Babajew, et al.
Nature (2021) Vol. 595, Iss. 7867, pp. 426-431
Open Access | Times Cited: 742
Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization
Pengfei Wang, Ryan G. Casner, Manoj S. Nair, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 5, pp. 747-751.e4
Open Access | Times Cited: 613
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
Matthew McCallum, Jessica Bassi, Anna De Marco, et al.
Science (2021) Vol. 373, Iss. 6555, pp. 648-654
Open Access | Times Cited: 439
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies
Allison J. Greaney, Tyler N. Starr, Christopher O. Barnes, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 402
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
Frauke Muecksch, Yiska Weisblum, Christopher O. Barnes, et al.
Immunity (2021) Vol. 54, Iss. 8, pp. 1853-1868.e7
Open Access | Times Cited: 281
Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
Alice Cho, Frauke Muecksch, Dennis Schaefer-Babajew, et al.
Nature (2021) Vol. 600, Iss. 7889, pp. 517-522
Open Access | Times Cited: 274
Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
Carmen Gómez, Beatriz Perdiguero, Mariano Estéban
Vaccines (2021) Vol. 9, Iss. 3, pp. 243-243
Open Access | Times Cited: 267
Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection
Allison J. Greaney, Andrea N. Loes, Lauren E. Gentles, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 600
Open Access | Times Cited: 241
The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies
Richard Copin, Alina Baum, Elzbieta Wloga, et al.
Cell (2021) Vol. 184, Iss. 15, pp. 3949-3961.e11
Open Access | Times Cited: 210
SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera
Alona Kuzmina, Yara Khalaila, Olga Voloshin, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 4, pp. 522-528.e2
Open Access | Times Cited: 192
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses
Alexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1137-1150.e6
Open Access | Times Cited: 188
SARS-CoV-2 Mutations and their Viral Variants
Begüm Coşar, Zeynep Yağmur KARAGÜLLEOĞLU, Sinan ÜNAL, et al.
Cytokine & Growth Factor Reviews (2021) Vol. 63, pp. 10-22
Open Access | Times Cited: 178
Emergence and Expansion of the SARS-CoV-2 Variant B.1.526 Identified in New York
Medini K. Annavajhala, Hiroshi Mohri, Pengfei Wang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 156
Evolutionary trajectory of SARS-CoV-2 and emerging variants
Jalen Singh, Pranav Pandit, Andrew G. McArthur, et al.
Virology Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 141
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429
Matthew McCallum, Jessica Bassi, Anna De Marco, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 138
Fast-spreading SARS-CoV-2 variants: challenges to and new design strategies of COVID-19 vaccines
Weilin Zhou, Wei Wang
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 132
Increased Resistance of SARS-CoV-2 Variant P.1 to Antibody Neutralization
Pengfei Wang, Ryan G. Casner, Manoj S. Nair, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 131
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants
Satoshi Ikegame, Mohammed Nure Alam Siddiquey, Chuan-Tien Hung, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 110
Detection of SARS-CoV-2 variants by genomic analysis of wastewater samples in Israel
Itay Bar-Or, Merav Weil, Victoria Indenbaum, et al.
The Science of The Total Environment (2021) Vol. 789, pp. 148002-148002
Open Access | Times Cited: 104
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
Claudia A. Jette, Alexander A. Cohen, Priyanthi N.P. Gnanapragasam, et al.
Cell Reports (2021) Vol. 36, Iss. 13, pp. 109760-109760
Open Access | Times Cited: 102
Current status of therapeutic monoclonal antibodies against SARS-CoV-2
Sanjeev Kumar, Anmol Chandele, Amit Sharma
PLoS Pathogens (2021) Vol. 17, Iss. 9, pp. e1009885-e1009885
Open Access | Times Cited: 97
HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens
Will Fischer, Elena E. Giorgi, Srirupa Chakraborty, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1093-1110
Open Access | Times Cited: 90
The emergence of new strains of SARS-CoV-2. What does it mean for COVID-19 vaccines?
Md Kamal Hossain, Majid Hassanzadeganroudsari, Vasso Apostolopoulos
Expert Review of Vaccines (2021) Vol. 20, Iss. 6, pp. 635-638
Open Access | Times Cited: 87
Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity
Shang Yu Gong, Debashree Chatterjee, Jonathan Richard, et al.
Virology (2021) Vol. 563, pp. 134-145
Open Access | Times Cited: 85
Page 1 - Next Page

Scroll to top